ICOS and Parkinson disease: identified that in A53 transgenic (A53T) PD mice, the expression levels of cytotoxic-T-lymphocyte-antigen-4 (CTLA-4) and inducible costimulator (ICOS) were markedly reduced in T regulatory lymphocytes (Tregs), a critical player in maintaining immune homeostasis (63).